Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sinobioway Group
Vaccines
Sinovac aborts go-private deal amid bizarre fight for control
Nasdaq-listed Sinovac accused OrbiMed, 1Globe Capital and a buyer consortium led by Sinobioway of conspiring a hostile takeover.
Angus Liu
Jul 10, 2018 11:01am
FiercePharmaAsia—WuXi, SinoBioway, Takeda and more
May 18, 2018 9:10am
WuXi and Sinobioway add capacity to nab wave of biologics
May 17, 2018 9:05am
CDMO Sinobioway bets big on China’s exploding biologics demand
May 14, 2018 9:25am
CureVac, Bavarian Nordic and more—News of Note
May 9, 2018 10:45am
European Commission, Sinovac drama and more—News of Note
Apr 25, 2018 9:26am
